Emma Mongkhoun, Ons Amamou, Christophe Piesse, Philippe Guégan, Nicolas Illy
{"title":"Nucleophilic Initiation of Episulfide Anionic Ring-Opening Polymerization by Amino Acids and Oligopeptides.","authors":"Emma Mongkhoun, Ons Amamou, Christophe Piesse, Philippe Guégan, Nicolas Illy","doi":"10.1021/acs.biomac.5c01251","DOIUrl":null,"url":null,"abstract":"<p><p>Peptide-polymer conjugates are promising molecules because they combine the biological functionality of peptides with the versatile properties of polymers, enabling applications in drug delivery, biomaterials, and nanomedicine with enhanced stability, biocompatibility, and tailored functionalities. Until now, the grafting-to approach has been the predominant strategy for synthesizing these biohybrids. By comparison, grafting-from techniques are relatively less diverse. Mainly, radical grafting-from techniques have also been developed, but they present a number of limitations, including a limited variety of polymerizable monomers and the introduction of nonbiodegradable polymer chains. The AROP-based grafting-from strategy offers a promising, yet still underexplored, route for synthesizing peptide-polymer conjugates bearing heteroatom-containing polymer side chains. We report an original AROP grafting-from strategy using primary amines as attachment sites, <i>N</i>-acetyl homocysteine thiolactone as a linker, and propylene sulfide as a monomer. The grafting-from technique was optimized using various protected and unprotected amino acids as model scaffolds. In addition, the regioselective functionalization of primary amine lateral substituents of lysine residues over chain-end amines was demonstrated. The method was then extended to dipeptides and tripeptides. Surprisingly, the grafting-from polymerization was demonstrated to also occur in a controlled manner using oligopeptide initiators bearing unprotected terminal carboxylic acid end-groups. Furthermore, this technique was applied to the introduction of polythioether grafts on the KLVFF peptide sequence (Lys-Leu-Val-Phe-Phe), which is a key recognition motif found in the amyloid-β (Aβ) protein, a protein strongly associated with Alzheimer's disease.</p>","PeriodicalId":30,"journal":{"name":"Biomacromolecules","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomacromolecules","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1021/acs.biomac.5c01251","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Peptide-polymer conjugates are promising molecules because they combine the biological functionality of peptides with the versatile properties of polymers, enabling applications in drug delivery, biomaterials, and nanomedicine with enhanced stability, biocompatibility, and tailored functionalities. Until now, the grafting-to approach has been the predominant strategy for synthesizing these biohybrids. By comparison, grafting-from techniques are relatively less diverse. Mainly, radical grafting-from techniques have also been developed, but they present a number of limitations, including a limited variety of polymerizable monomers and the introduction of nonbiodegradable polymer chains. The AROP-based grafting-from strategy offers a promising, yet still underexplored, route for synthesizing peptide-polymer conjugates bearing heteroatom-containing polymer side chains. We report an original AROP grafting-from strategy using primary amines as attachment sites, N-acetyl homocysteine thiolactone as a linker, and propylene sulfide as a monomer. The grafting-from technique was optimized using various protected and unprotected amino acids as model scaffolds. In addition, the regioselective functionalization of primary amine lateral substituents of lysine residues over chain-end amines was demonstrated. The method was then extended to dipeptides and tripeptides. Surprisingly, the grafting-from polymerization was demonstrated to also occur in a controlled manner using oligopeptide initiators bearing unprotected terminal carboxylic acid end-groups. Furthermore, this technique was applied to the introduction of polythioether grafts on the KLVFF peptide sequence (Lys-Leu-Val-Phe-Phe), which is a key recognition motif found in the amyloid-β (Aβ) protein, a protein strongly associated with Alzheimer's disease.
肽-聚合物缀合物是很有前途的分子,因为它们结合了肽的生物功能和聚合物的多用途特性,使药物输送、生物材料和纳米医学的应用具有增强的稳定性、生物相容性和定制的功能。到目前为止,嫁接方法一直是合成这些生物杂交种的主要策略。相比之下,嫁接技术的多样性相对较少。主要的是,自由基接枝技术也得到了发展,但它们存在一些局限性,包括可聚合单体的种类有限,以及引入不可生物降解的聚合物链。基于arop的接枝策略为合成含有杂原子的聚合物侧链的肽-聚合物共轭物提供了一条很有前途但尚未开发的途径。我们报道了一种原始的AROP接枝策略,使用伯胺作为连接位点,n -乙酰同型半胱氨酸硫内酯作为连接剂,硫化丙为单体。以多种受保护和未受保护的氨基酸为模型支架,对接枝技术进行了优化。此外,还证实了赖氨酸残基的伯胺侧取代基在链端胺上的区域选择性功能化。然后将该方法扩展到二肽和三肽。令人惊讶的是,聚合的接枝也被证明以一种受控的方式发生,使用带有无保护末端羧酸端基的寡肽引发剂。此外,该技术还应用于在KLVFF肽序列(Lys-Leu-Val-Phe-Phe)上引入聚硫醚移植物,该序列是淀粉样蛋白-β (a β)蛋白中发现的关键识别基序,该蛋白与阿尔茨海默病密切相关。
期刊介绍:
Biomacromolecules is a leading forum for the dissemination of cutting-edge research at the interface of polymer science and biology. Submissions to Biomacromolecules should contain strong elements of innovation in terms of macromolecular design, synthesis and characterization, or in the application of polymer materials to biology and medicine.
Topics covered by Biomacromolecules include, but are not exclusively limited to: sustainable polymers, polymers based on natural and renewable resources, degradable polymers, polymer conjugates, polymeric drugs, polymers in biocatalysis, biomacromolecular assembly, biomimetic polymers, polymer-biomineral hybrids, biomimetic-polymer processing, polymer recycling, bioactive polymer surfaces, original polymer design for biomedical applications such as immunotherapy, drug delivery, gene delivery, antimicrobial applications, diagnostic imaging and biosensing, polymers in tissue engineering and regenerative medicine, polymeric scaffolds and hydrogels for cell culture and delivery.